OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study
Tommy Nyberg, Neil M. Ferguson, Sophie Nash, et al.
The Lancet (2022) Vol. 399, Iss. 10332, pp. 1303-1312
Open Access | Times Cited: 1150
Tommy Nyberg, Neil M. Ferguson, Sophie Nash, et al.
The Lancet (2022) Vol. 399, Iss. 10332, pp. 1303-1312
Open Access | Times Cited: 1150
Showing 26-50 of 1150 citing articles:
Omicron variant (B.1.1.529) and its sublineages: What do we know so far amid the emergence of recombinant variants of SARS-CoV-2?
Manish Dhawan, AbdulRahman A. Saied, Saikat Mitra, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 154, pp. 113522-113522
Open Access | Times Cited: 93
Manish Dhawan, AbdulRahman A. Saied, Saikat Mitra, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 154, pp. 113522-113522
Open Access | Times Cited: 93
Omicron-associated changes in SARS-CoV-2 symptoms in the United Kingdom
Karina-Doris Vihta, Koen B. Pouwels, Tim Peto, et al.
Clinical Infectious Diseases (2022)
Open Access | Times Cited: 90
Karina-Doris Vihta, Koen B. Pouwels, Tim Peto, et al.
Clinical Infectious Diseases (2022)
Open Access | Times Cited: 90
Efficacy of SARS-CoV-2 vaccines and the dose–response relationship with three major antibodies: a systematic review and meta-analysis of randomised controlled trials
Zhirong Yang, Yi-Wen Jiang, Fu-Xiao Li, et al.
The Lancet Microbe (2023) Vol. 4, Iss. 4, pp. e236-e246
Open Access | Times Cited: 89
Zhirong Yang, Yi-Wen Jiang, Fu-Xiao Li, et al.
The Lancet Microbe (2023) Vol. 4, Iss. 4, pp. e236-e246
Open Access | Times Cited: 89
Risk of autoimmune diseases following COVID-19 and the potential protective effect from vaccination: a population-based cohort study
Kuan Peng, Xue Li, Deliang Yang, et al.
EClinicalMedicine (2023) Vol. 63, pp. 102154-102154
Open Access | Times Cited: 88
Kuan Peng, Xue Li, Deliang Yang, et al.
EClinicalMedicine (2023) Vol. 63, pp. 102154-102154
Open Access | Times Cited: 88
Cognition and Memory after Covid-19 in a Large Community Sample
Adam Hampshire, Adriana Azor, Christina Atchison, et al.
New England Journal of Medicine (2024) Vol. 390, Iss. 9, pp. 806-818
Open Access | Times Cited: 87
Adam Hampshire, Adriana Azor, Christina Atchison, et al.
New England Journal of Medicine (2024) Vol. 390, Iss. 9, pp. 806-818
Open Access | Times Cited: 87
Clinical outcomes associated with Omicron (B.1.1.529) variant and BA.1/BA.1.1 or BA.2 subvariant infection in southern California
Joseph A. Lewnard, Vennis Hong, Manish M. Patel, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 81
Joseph A. Lewnard, Vennis Hong, Manish M. Patel, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 81
SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease
Eleanor Barnes, Carl S. Goodyear, Michelle Willicombe, et al.
Nature Medicine (2023) Vol. 29, Iss. 7, pp. 1760-1774
Open Access | Times Cited: 80
Eleanor Barnes, Carl S. Goodyear, Michelle Willicombe, et al.
Nature Medicine (2023) Vol. 29, Iss. 7, pp. 1760-1774
Open Access | Times Cited: 80
Clinical Characteristics and Outcomes of Immunocompromised Patients With Coronavirus Disease 2019 Caused by the Omicron Variant: A Prospective, Observational Study
S. Reshwan K. Malahe, Rogier A.S. Hoek, Virgil A. S. H. Dalm, et al.
Clinical Infectious Diseases (2022) Vol. 76, Iss. 3, pp. e172-e178
Open Access | Times Cited: 78
S. Reshwan K. Malahe, Rogier A.S. Hoek, Virgil A. S. H. Dalm, et al.
Clinical Infectious Diseases (2022) Vol. 76, Iss. 3, pp. e172-e178
Open Access | Times Cited: 78
Remdesivir for the treatment of COVID-19
Felicitas Grundeis, Kelly Ansems, Karolina Dahms, et al.
Cochrane library (2023) Vol. 2023, Iss. 1
Closed Access | Times Cited: 77
Felicitas Grundeis, Kelly Ansems, Karolina Dahms, et al.
Cochrane library (2023) Vol. 2023, Iss. 1
Closed Access | Times Cited: 77
Comparative effectiveness of sotrovimab and molnupiravir for prevention of severe covid-19 outcomes in patients in the community: observational cohort study with the OpenSAFELY platform
Bang Zheng, Amelia Green, John Tazare, et al.
BMJ (2022), pp. e071932-e071932
Open Access | Times Cited: 75
Bang Zheng, Amelia Green, John Tazare, et al.
BMJ (2022), pp. e071932-e071932
Open Access | Times Cited: 75
SARS-CoV-2 Omicron variants BA.1 and BA.2 both show similarly reduced disease severity of COVID-19 compared to Delta, Germany, 2021 to 2022
Claudia Sievers, Benedikt Zacher, Alexander Ullrich, et al.
Eurosurveillance (2022) Vol. 27, Iss. 22
Open Access | Times Cited: 73
Claudia Sievers, Benedikt Zacher, Alexander Ullrich, et al.
Eurosurveillance (2022) Vol. 27, Iss. 22
Open Access | Times Cited: 73
Protection against symptomatic infection with delta (B.1.617.2) and omicron (B.1.1.529) BA.1 and BA.2 SARS-CoV-2 variants after previous infection and vaccination in adolescents in England, August, 2021–March, 2022: a national, observational, test-negative, case-control study
Annabel Powell, Freja Kirsebom, Julia Stowe, et al.
The Lancet Infectious Diseases (2022) Vol. 23, Iss. 4, pp. 435-444
Open Access | Times Cited: 73
Annabel Powell, Freja Kirsebom, Julia Stowe, et al.
The Lancet Infectious Diseases (2022) Vol. 23, Iss. 4, pp. 435-444
Open Access | Times Cited: 73
Current and Emerging Knowledge in COVID-19
Yeon Joo Jeong, Yu Mi Wi, Hyunjin Park, et al.
Radiology (2023) Vol. 306, Iss. 2
Open Access | Times Cited: 72
Yeon Joo Jeong, Yu Mi Wi, Hyunjin Park, et al.
Radiology (2023) Vol. 306, Iss. 2
Open Access | Times Cited: 72
Long-term post-acute sequelae of COVID-19 infection: a retrospective, multi-database cohort study in Hong Kong and the UK
Ivan Chun Hang Lam, Carlos King Ho Wong, Ran Zhang, et al.
EClinicalMedicine (2023) Vol. 60, pp. 102000-102000
Open Access | Times Cited: 72
Ivan Chun Hang Lam, Carlos King Ho Wong, Ran Zhang, et al.
EClinicalMedicine (2023) Vol. 60, pp. 102000-102000
Open Access | Times Cited: 72
Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey
Livio Pagano, Jon Salmanton‐García, Francesco Marchesi, et al.
Blood (2022) Vol. 140, Iss. 26, pp. 2773-2787
Open Access | Times Cited: 69
Livio Pagano, Jon Salmanton‐García, Francesco Marchesi, et al.
Blood (2022) Vol. 140, Iss. 26, pp. 2773-2787
Open Access | Times Cited: 69
Outcome of COVID-19 in hospitalised immunocompromised patients: An analysis of the WHO ISARIC CCP-UK prospective cohort study
Lance Turtle, Mathew Thorpe, Thomas M Drake, et al.
PLoS Medicine (2023) Vol. 20, Iss. 1, pp. e1004086-e1004086
Open Access | Times Cited: 66
Lance Turtle, Mathew Thorpe, Thomas M Drake, et al.
PLoS Medicine (2023) Vol. 20, Iss. 1, pp. e1004086-e1004086
Open Access | Times Cited: 66
SARS-CoV-2 variants evolve convergent strategies to remodel the host response
Mehdi Bouhaddou, Ann‐Kathrin Reuschl, Benjamin J. Polacco, et al.
Cell (2023) Vol. 186, Iss. 21, pp. 4597-4614.e26
Open Access | Times Cited: 65
Mehdi Bouhaddou, Ann‐Kathrin Reuschl, Benjamin J. Polacco, et al.
Cell (2023) Vol. 186, Iss. 21, pp. 4597-4614.e26
Open Access | Times Cited: 65
Impact of COVID-19 on Cardiovascular Disease
Ivan Vosko, Andreas Zirlik, Heiko Bugger
Viruses (2023) Vol. 15, Iss. 2, pp. 508-508
Open Access | Times Cited: 63
Ivan Vosko, Andreas Zirlik, Heiko Bugger
Viruses (2023) Vol. 15, Iss. 2, pp. 508-508
Open Access | Times Cited: 63
Comparative transmission of SARS-CoV-2 Omicron (B.1.1.529) and Delta (B.1.617.2) variants and the impact of vaccination: national cohort study, England
Hester Allen, Elise Tessier, Charlie Turner, et al.
Epidemiology and Infection (2023) Vol. 151
Open Access | Times Cited: 63
Hester Allen, Elise Tessier, Charlie Turner, et al.
Epidemiology and Infection (2023) Vol. 151
Open Access | Times Cited: 63
Changes in COVID-19-related mortality across key demographic and clinical subgroups in England from 2020 to 2022: a retrospective cohort study using the OpenSAFELY platform
Linda Nab, Edward P K Parker, Colm Andrews, et al.
The Lancet Public Health (2023) Vol. 8, Iss. 5, pp. e364-e377
Open Access | Times Cited: 59
Linda Nab, Edward P K Parker, Colm Andrews, et al.
The Lancet Public Health (2023) Vol. 8, Iss. 5, pp. e364-e377
Open Access | Times Cited: 59
Clinical outcomes of the severe acute respiratory syndrome coronavirus 2 Omicron and Delta variant: systematic review and meta-analysis of 33 studies covering 6 037 144 coronavirus disease 2019–positive patients
Feihong Hu, Yijie Jia, Dan‐Yan Zhao, et al.
Clinical Microbiology and Infection (2023) Vol. 29, Iss. 7, pp. 835-844
Open Access | Times Cited: 56
Feihong Hu, Yijie Jia, Dan‐Yan Zhao, et al.
Clinical Microbiology and Infection (2023) Vol. 29, Iss. 7, pp. 835-844
Open Access | Times Cited: 56
Efficacy and Safety of 5-Day Oral Ensitrelvir for Patients With Mild to Moderate COVID-19
Hiroshi Yotsuyanagi, Norio Ohmagari, Yohei Doi, et al.
JAMA Network Open (2024) Vol. 7, Iss. 2, pp. e2354991-e2354991
Open Access | Times Cited: 51
Hiroshi Yotsuyanagi, Norio Ohmagari, Yohei Doi, et al.
JAMA Network Open (2024) Vol. 7, Iss. 2, pp. e2354991-e2354991
Open Access | Times Cited: 51
SARS-CoV-2 Omicron variants: burden of disease, impact on vaccine effectiveness and need for variant-adapted vaccines
Shanti Pather, Shabir A. Madhi, Benjamin J. Cowling, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 49
Shanti Pather, Shabir A. Madhi, Benjamin J. Cowling, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 49
Severity and outcomes of Omicron variant of SARS-CoV-2 compared to Delta variant and severity of Omicron sublineages: a systematic review and metanalysis
Pryanka Relan, Nkengafac Villyen Motaze, Kavita Kothari, et al.
BMJ Global Health (2023) Vol. 8, Iss. 7, pp. e012328-e012328
Open Access | Times Cited: 49
Pryanka Relan, Nkengafac Villyen Motaze, Kavita Kothari, et al.
BMJ Global Health (2023) Vol. 8, Iss. 7, pp. e012328-e012328
Open Access | Times Cited: 49
A one-year follow-up study of systematic impact of long COVID symptoms among patients post SARS-CoV-2 omicron variants infection in Shanghai, China
Jianpeng Cai, Ke Lin, Haocheng Zhang, et al.
Emerging Microbes & Infections (2023) Vol. 12, Iss. 2
Open Access | Times Cited: 48
Jianpeng Cai, Ke Lin, Haocheng Zhang, et al.
Emerging Microbes & Infections (2023) Vol. 12, Iss. 2
Open Access | Times Cited: 48
